Ms. Shima Bahri | Decision-making and Problem-solving | Best Researcher Award

Ms. Shima Bahri | Decision-making and Problem-solving | Best Researcher Award

Shahid Beheshti University of Medical Sciences | Iran

Dr. Shima Bahri is a pharmaceutical researcher specializing in the preparation, characterization, and in vivo evaluation of nanoparticles, including liposomes, cerasomes, and quantum dots. She obtained her Ph.D. in Pharmaceutical Nanotechnology from Shahid Beheshti University of Medical Sciences, Tehran, Iran (2016–2023), where her thesis focused on the Accelerated Blood Clearance (ABC) phenomenon following IV injection of composite nanocerasomes, earning an excellent grade and a GPA of 17.21/20. She completed her M.Sc. in Organic Chemistry at Isfahan University of Technology (2012–2014), with research on carbon-heteroatom cross-coupling reactions and indazole synthesis, and her B.Sc. in Pure Chemistry from Sharif University of Technology (2007–2011). Dr. Bahri has in-depth expertise in nanoparticle preparation, in vitro characterization, synthesis, purification, and pharmacokinetic studies, employing analytical techniques such as LC-MS, FT-IR, NMR, UV spectroscopy, DLS, TEM, SEM, and atomic absorption spectroscopy. Her research has produced 9 documents with 9 citations and an h-index of 2. She has been recognized for her top performance in national Ph.D. and university entrance exams. Dr. Bahri’s work aims to advance safe and effective nanocarrier systems for drug delivery. Her dedication to innovation and excellence underscores her growing contribution to pharmaceutical nanotechnology.

Profile:  Google Scholar 

Featured Publications

Hajipour, A. R., Khorsandi, Z., & Bahri, S. (2018). An efficient and inexpensive visible light photoredox copper catalyst for N–N bond-forming reactions: The one-pot synthesis of indazolo[2,3-α]quinolines. Journal of the Iranian Chemical Society, 15(4), 981–986.

Bahri, S., Abdollahizad, E., Mahlooji, I., Rezaee, E., Abbasian, Z., … [add remaining authors if desired]. (2023). Cerasome versus liposome: A comparative pharmacokinetic analysis following intravenous administration into rats. Iranian Journal of Pharmaceutical Research: IJPR, 22(1).

Abdollahizad, E., Dadashzadeh, S., Bahri, S., Abbasian, Z., & Rezaee, E. (2023). Amphotericin B pharmacokinetics: Inter-strain differences in rats following intravenous administration of the most commonly marketed formulations of the drug. Iranian Journal of Pharmaceutical Research: IJPR, 22(1).

Bahri, S., Qaribnejad, A., Soleimanjahi, H., Rezaee, E., Haeri, A., … [add remaining authors if desired]. (2025). Pegylated cerasomes exhibit accelerated blood clearance in rats despite no elevation of anti-PEG IgM and IgG antibodies. International Journal of Pharmaceutics, 126185.

Hajipour, A. R., Bahri, S., & MohammadSaleh, F. (Year?). Choline chloride/CuCl as an effective homogeneous catalyst for palladium-free CN cross-coupling reactions.

Mr. Ajmal Khan | Biology | Best Researcher Award

Mr. Ajmal Khan | Biology | Best Researcher Award |

KU Leuven | Belgium

Dr. Ajmal Khan is a dedicated life sciences researcher specializing in pharmacology, drug discovery, and preclinical screening, with a Ph.D. in Biology from KU Leuven, Belgium. His research focuses on evaluating bioactive compounds from traditional medicinal plants for antimicrobial, antiparasitic, anticancer, and cytotoxic potential using advanced in vitro and in vivo bioassays and high-resolution mass spectrometry. With extensive academic and professional experience, he has taught and supervised undergraduate and graduate students, conducted practical laboratory courses, and managed research projects in pharmacology, microbiology, parasitology, and molecular biology. He has authored 42 publications with a total of 42 citations and an h-index of 3, reflecting his growing impact in the scientific community. Dr. Khan’s work integrates expertise in microbial and cell culture techniques, bioassays, plant extraction, chromatography, and spectroscopy, alongside skills in bioinformatics, molecular biology, and statistical analysis. He has actively contributed to academic leadership, community engagement, and youth development through various organizational roles. His research advances the discovery and preclinical evaluation of novel therapeutic compounds, demonstrating both scientific rigor and societal relevance. With his interdisciplinary expertise, innovative approach, and commitment to translational research, Dr. Khan represents a strong candidate for recognition in research excellence and impact.

Profile:  Google Scholar

Featured Publications

“Bioassay-guided interpretation of antimicrobial compounds in Kumu, a TCM preparation from Picrasma quassioides’ stem via UHPLC-Ion Trap-Orbitrap Mass Spectrometry combined with …”

“Antileishmanial Potential of Berberine Alkaloids From Berberis glaucocarpa Roots: Molecular Docking Suggests Relevant Leishmania Protein Targets”

“A report on prevalence of malaria infection in general population of Bajaur Agency, FATA, Pakistan”